Methyl 3'-bromo-[1,1'-biphenyl]-4-carboxylate, 95%, 500mg

4-(Benzyloxy)-3-ethylbenzoic acid, 98%, 500mg

(4-Aminopyrimidin-5-yl)methanol, 95+%, 500mg

2-(4-METHOXYPHENYL)PIPERIDINE HCL, 95.0%, 250mg

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-Bromo-1-ethynyl-4-fluorobenzene, 97%, 250mg

2,5-Dimethylfuran-3(2H)-one, 97.0%, 25g

2,2-Difluorocyclopropanecarboxamide, 97%, 1g

2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-, (2E)-, 100mg

4'-Ethyl-biphenyl-4-ol, 97.0%, 250mg

1-(5-Methylpyridin-3-yl)ethanone, 95.0%, 1g

7-Bromo-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine, 98%, 250mg

tri-calcium dicitrate tetrahydrate, min. 97%, extra pure, 2.5 kg, plastic packaging.